Search research articles
Contact Us
Filters
Showing results (1-10 of 99) with videos related to
Page
of 10
Sort By:
The Journal of Clinical Investigation
|
December 24, 2008
CD4+ T cells mediate cytotoxicity in neurodegenerative diseases
Stanley H Appel
Current Opinion in Pharmacology
|
March 17, 2004
Mutant genes responsible for Parkinson's disease
Weidong Le, Stanley H Appel
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 6, 2017
Introduction to supplement: the current status of treatment for ALS
Robert G Miller, Stanley H Appel
Journal of Neuroimmunology
|
September 27, 2003
Serum anti-Fas antibody levels in amyotrophic lateral sclerosis
Ihsan S Sengun, Stanley H Appel
The Lancet. Neurology
|
January 22, 2019
Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies
David R Beers, Stanley H Appel
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
July 25, 2013
Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis
Weihua Zhao, David R Beers, Stanley H Appel
Journal of Neurology
|
June 15, 2006
Amyotrophic lateral sclerosis: early predictors of prolonged survival
Adam Czaplinski, Albert A Yen, Stanley H Appel
Experimental Neurology
|
October 3, 2002
Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra
Yi He, Wei-Dong Le, Stanley H Appel
Current Opinion in Neurology
|
August 17, 2021
Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration
Stanley H Appel, David R Beers, Weihua Zhao
Current Opinion in Rheumatology
|
October 22, 2003
Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis
Ericka P Simpson, Albert A Yen, Stanley H Appel
Page
of 10
Search research articles
Search
Showing results (1-10 of 99) with videos related to
Sort By:
Page
of 10
The Journal of Clinical Investigation
|
December 24, 2008
CD4+ T cells mediate cytotoxicity in neurodegenerative diseases
Stanley H Appel
Current Opinion in Pharmacology
|
March 17, 2004
Mutant genes responsible for Parkinson's disease
Weidong Le, Stanley H Appel
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 6, 2017
Introduction to supplement: the current status of treatment for ALS
Robert G Miller, Stanley H Appel
Journal of Neuroimmunology
|
September 27, 2003
Serum anti-Fas antibody levels in amyotrophic lateral sclerosis
Ihsan S Sengun, Stanley H Appel
The Lancet. Neurology
|
January 22, 2019
Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies
David R Beers, Stanley H Appel
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
July 25, 2013
Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis
Weihua Zhao, David R Beers, Stanley H Appel
Journal of Neurology
|
June 15, 2006
Amyotrophic lateral sclerosis: early predictors of prolonged survival
Adam Czaplinski, Albert A Yen, Stanley H Appel
Experimental Neurology
|
October 3, 2002
Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra
Yi He, Wei-Dong Le, Stanley H Appel
Current Opinion in Neurology
|
August 17, 2021
Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration
Stanley H Appel, David R Beers, Weihua Zhao
Current Opinion in Rheumatology
|
October 22, 2003
Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis
Ericka P Simpson, Albert A Yen, Stanley H Appel
Page
of 10